Refine Results
  1. "Adult Leukemia"
Formats
  1. Journal Article (795)
  2. Meeting Abstract (671)
  3. Book Section (18)
  4. Conference Paper (1)
Groups
  1. Adult Leukemia (1485)
  2. Center for Hematologic Malignancies (1485)
  3. Hematologic Oncology, Division of (1442)
  4. Leukemia Service (1441)
  5. Leukemia Disease Management Team (1119)
  6. Human Oncology and Pathogenesis Program (541)

More Groups

People
  1. Ross Levine (462)
  2. Martin Tallman (387)
  3. Omar Abdel-Wahab (192)
  4. David Scheinberg (143)
  5. Raajit Rampal (122)
  6. Michael Mauro (113)

More People

Years
  1. 2019 (2)
  2. 2018 (148)
  3. 2017 (174)
  4. 2016 (165)
  5. 2015 (181)
  6. 2014 (182)

More Years

Publications
  1. Blood (498)
  2. Haematologica (66)
  3. Journal of Clinical Oncology (60)
  4. Cancer Research (45)
  5. Leukemia (45)
  6. Clinical Lymphoma, Myeloma and Leukemia (37)

More Publications

Publishers
  1. American Society of Hematology (514)
  2. Nature Publishing Group (149)
  3. American Association for Cancer Research (100)
  4. Elsevier Inc. (91)
  5. Ferrata Storti Foundation (66)
  6. American Society of Clinical Oncology (65)

More Publishers

Results (1485)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease
    Journal Article

    Litzow, M. R.; Wang, X. V.; Carroll, M. P.; Karp, J. E.; Ketterling, R. P.; Zhang, Y.; Kaufmann, S. H.; Lazarus, H. M.; Luger, S. M.; Paietta, E. M.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY
    Journal Article

    Hehlmann, R.; Cortes, J. E.; Zyczynski, T.; Gambacorti-Passerini, C.; Goldberg, S. L.; Mauro, M. J.; Michallet, M.; Simonsson, B.; Williams, L. A.; Gajavelli, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • AGILE: A phase 3, multicenter, randomized, placebo-controlled study of ivosidenib in combination with azacitidine in adult patients with previously untreated acute myeloid leukemia with an IDH1 mutation
    Meeting Abstract

    Stein, E.; Dinardo, C. D.; Jang, J. H.; Miyazaki, Y.; Martinez, R. O.; Auer, J.; Zhang, V.; Koralek, D. O.; Wu, B.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 2 study to assess the safety and efficacy of umbralisib (TGR-1202) in pts with CLL who are intolerant to prior BTK or PI3Kδ inhibitor therapy
    Meeting Abstract

    Mato, A. R.; Schuster, S. J.; Lamanna, N.; Flinn, I.; Barrientos, J. C.; Kambhampati, S.; Cheson, B. D.; Barr, P. M.; Pagel, J. M.; Reeves, J. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical development of asciminib (ABL001) in chronic myeloid leukemia (CML): A randomized phase 3 study vs. bosutinib
    Meeting Abstract

    Mauro, M. J.; Lang, F.; Kim, D. W.; Cortes, J. E.; Hughes, T. P.; Hochhaus, A.; Minami, H.; Boquimpani, C.; Minami, Y.; DeAngelo, D. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Management and outcomes of 222 CLL patients (pts) treated with venetoclax (VEN) in the real world
    Meeting Abstract

    Nabhan, C.; Klink, A.; Samp, J.; Pauff, J. M.; Nielsen, J.; Meissner, B.; Keim, H.; Kennard, K.; Mato, A. R.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A US-based survey: The experiences of 1147 chronic lymphocytic leukemia (CLL) patients (pts)
    Meeting Abstract

    Koffman, B.; Dennison, B.; Kennard, K.; Byrd, J. C.; Pagel, J. M.; Davids, M. S.; Nabhan, C.; Kay, N. E.; Siddiqi, T.; Brander, D. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Mitigation of tumor lysis syndrome (TLS) complications with venetoclax (VEN) in CLL
    Meeting Abstract

    Davids, M. S.; Seymour, J. F.; Roberts, A. W.; Eichhorst, B.; Kipps, T. J.; Mato, A. R.; Stilgenbauer, S.; Mobasher, M.; Desai, M. B.; Potluri, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Durability of response to venetoclax (VEN) in patients with CLL relapsed/refractory to ibrutinib and/or idelalisib
    Meeting Abstract

    Byrd, J. C.; Wierda, W. G.; Davids, M. S.; Choi, M. Y.; Furman, R. R.; Mato, A. R.; Zhou, L.; Verdugo, M. E.; Potluri, J.; Coutre, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The prognostic value of systemic inflammation in patients undergoing surgery for rectal cancer: Comparison of composite ratios and cumulative scores
    Meeting Abstract

    Dolan, R.; McSorley, S. T.; Park, J. H.; Roxburgh, C. S. D.; Horgan, P. G.; McMillan, D. C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save